KRISTINA VANG: Open Payments
NPI 1801579008 · BELLEVUE, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$168 in 10 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $29 · 2025 $168
Food & beverage: $168
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $44 |
| Lilly USA, LLC | 3 | $44 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $19 |
| Novo Nordisk Inc | 1 | $17 |
| PFIZER INC. | 1 | $17 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $14 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: CAPLYTA, MOUNJARO, Rybelsus, Kerendia, FARXIGA.
Industry payments across NE — which companies pay providers there.
